A mindfulness-based cognitive therapy program shows positive effects on quality of life, emotional status and immune status of people with HIV.
Dolutegravir is an integrase inhibitor with a higher efficiency to other antiretroviral drugs.
From 26 to 28 March, doctors Santos and Llibre will present recent results in their studies in the field of clinical virology.
Presented at the CROI the results of a new study on the NEU instrument for the detection of central nervous system disturbances caused by HIV.
This recognition has been given because of the candidates curricular merits and the quality and impact of their scientific proposals.
Dr. Eugenia Negredo signs a poster as first author on the treatment of osteoporosis in people with HIV.
© Fundación Lucha contra el Sida · All rights reserved